Fundz

Carrick Therapeutics Closes Series C Financing

PRIVATEDec 01, 2022

Round Type

Series C

DublinBiotechnologyHealth Care

Description

Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced it has raised $25 million in a Series C financing. The financing round was supported by existing investors, including ARCH Venture Partners, Rosetta Capital, Lightstone Ventures, Google Ventures, Cambridge Innovation Capital, and Evotec. The Company intends to use the proceeds to fund ongoing and planned samuraciclib clinical trials, ongoing development of its CDK12/13 inhibitor / Cyclin-K glue-degrader, and for working capital and general corporate purposes.

Quick answer

Carrick raised an undisclosed amount in a Series C round, dated December 1, 2022. Carrick is based in Dublin, California, United States.

How much did Carrick raise?
Carrick raised an undisclosed amount in a Series C round on December 1, 2022.
What does Carrick do?
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s..
Where is Carrick based and how big is it?
Carrick is based in Dublin, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Carrick that raised within 45 days of this round, from Fundz verified event records.

  • DeepLook Medical raised $1.5M (Seed) on January 13, 2023.
  • Wheeler Bio raised an undisclosed amount (Funding Round) on January 12, 2023.
  • LinusBio raised $16M (Funding Round) on January 12, 2023.
  • Vero Biotech Inc. raised $30M (Funding Round) on January 11, 2023.
  • MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
  • ReCode Therapeutics raised an undisclosed amount (Corporate Round) on January 10, 2023.

Who to call at Carrick, and when

A new round usually means Carrick is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Carrick raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Carrick, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Carrick. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Carrick

Location

Dublin, California, United States

About

Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Carrick raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Carrick's next move

See what Strategic adds

Carrick raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.